Profile | GDS2987 / GI_37538739-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 20.5 | 55 |
GSM215244 | HMVEC_vehicle_rep2 | 44.1 | 66 |
GSM215253 | HMVEC_vehicle_rep3 | 16.7 | 48 |
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | 31.4 | 57 |
GSM215344 | HMVEC_atorvastatin_rep2 | 35.7 | 61 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 42.3 | 61 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 7.3 | 13 |
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 37.2 | 52 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 55.7 | 65 |
GSM215312 | PASMC_atorvastatin_rep2 | 54.4 | 62 |
GSM215313 | PASMC_atorvastatin_rep3 | 55.4 | 61 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 63.9 | 67 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 19.3 | 32 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 33.7 | 52 |
GSM215329 | PASMC_SLx2119_rep3 | 40.4 | 59 |
GSM215330 | Fibroblasts_vehicle_rep1 | 11.7 | 27 |
GSM215331 | Fibroblasts_vehicle_rep2 | 12.4 | 34 |
GSM215332 | Fibroblasts_vehicle_rep3 | 14.8 | 44 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 20.2 | 47 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 9.4 | 26 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 2 | 5 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 11 | 35 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | ||
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | ||
GSM215339 | Fibroblasts_SLx2119_rep1 | 11.1 | 32 |
GSM215340 | Fibroblasts_SLx2119_rep2 | ||
GSM215341 | Fibroblasts_SLx2119_rep3 | 22.8 | 49 |